news-24

Recently, the crystallization team at Porton and Genentech, Inc. jointly published a paper titled “Phase Transitions Involving Channel Hydrates of a New Pharmaceutical Compound” in 《Pharmaceutical Research》, the official journal of the American Association of Pharmaceutical Scientists. This journal focuses on publication of new research results in the combined area of medicine and chemistry. Polymorphism

On June 14, 2024, Dr. Francesco Fontana (R&D Director), Dr. Dario Telese (Lead Chemist), and Dr. Lucija Ptiček (Synthesis Laboratory Specialist) from the Porton Slovenian site presented a lecture on the Master PRO-API program of the University of Perugia. The lecture, titled “Introduction to the Green Chemistry Metrics – Innovation Green Aspiration Level (iGAL),” The

June 2024 — Porton J-STAR today announced that Enabling Technologies Consortium (ETC) has awarded a two-year contract to J-STAR to collaborate on “Co-processing Platform Technology.” The primary goal of co-processing is to improve the reliability and efficiency of drug product manufacturing processes to support direct compression or continuous manufacturing techniques. Co-processed APIs offer solutions to

As the global market for biopharmaceutical research outsourcing continues to flourish, the annual BOS Basel Conference has once again drawn worldwide attention. Since its inception in 2006, the Biotech Outsourcing Strategies (BOS) Events has become a barometer for the research outsourcing industry in Europe and globally. The organizers invite industry experts, business leaders, and scholars

On May 22, 2024 the opening ceremony of the state-of-the-art research and development laboratories for active pharmaceutical ingredients (APIs), small molecules, of the Porton company took place in Mengeš. This marks another milestone of Porton’s globalization journey after the acquisition of J-STAR Research Inc., a US based CRO, in 2017. As the first foreign company who brought to Slovenia

We’ve had an exciting few days at CPhI North America. We want to express our sincere gratitude to all the present and potential future partners we’ve engaged with. Whether you require assistance with API route scouting, chemistry optimization, or the manufacturing of intermediates, RSM, or finished API, our teams are ready to support you from

The Swiss Biotech Day, hosted by the Swiss Biotech Association, stands as one of Europe’s leading biotechnology conferences. With a global reputation, last year’s event drew over 1,800 participants from 44 countries. In 2024, the conference will once again serve as a hub for networking, insightful discussions, and the exploration of cutting-edge developments in R&D,

NEW YORK, NY – From March 18th to March 21st, 2024, Midtown New York City hosted the 96th Annual DCAT Week, renowned as one of the world’s largest and most prestigious business events in the pharmaceutical industry. Over four days, hundreds of member companies engaged in high-level customer meetings, typically involving senior management or C-suite